Diabetes-induced adhesive capsulitis: the role of radial extracorporeal shock wave therapy on pain and the shoulder muscles strength
Erişim
info:eu-repo/semantics/closedAccessTarih
2020Yazar
Çevik Saldıran, TülayAkgöl, Ahmet Cüneyt
Yazgan, Pelin
Özdemir, Asena
Karantay Mutluay, Fatma
Üst veri
Tüm öğe kaydını gösterKünye
Çevik Saldıran, T., Akgöl, A. C., Yazgan, P., Özdemir, A. ve Karantay Mutluay, F. (2020). Diabetes-induced adhesive capsulitis: the role of radial extracorporeal shock wave therapy on pain and the shoulder muscles strength. Diabetes Technology & Therapeutics içinde (A194-A195. ss.).Özet
Background and Aims: The study aimed to determine thechanges in the shoulder pain and muscle strength in patients with diabetes-induced adhesive capsulitis (DIAC) when the differentdose of Radial Extracorporeal Shock Wave Therapies (rESWT)applied.Methods: This double-blind randomized clinical trial conductedat Okan University Research Hospital (Istanbul) with patients referredfrom multiple centers. Participants were ‡45years (mean53.49 – 5.81 years), had T2D for ‡3years (meanduration9.92–5.70years), had DIAC, had HbA1c£ 9.0% (mean 7.38 – 0.76%); werebeing treated with inadequately basal insulin (20.5%) and oral antidiabeticdrugs (79.5%) were enrolled. The rESWT was appliedwith Enraf Nonius Endoplus device with a 25mm applicator, at 8Hz,and with 2000 beats. The participants were randomly assigned tothree groups as follows: high dose rESWT (hrESWT, n = 13),moderate dose rESWT(mrESWT, n =13) or placebo rESWT group(prESWT, n = 13). The primary outcomes were Visual Analog Scale(VAS) for pain and dynamometer evaluations for shoulder musclestrength for over the 4th and 6th week of the trial.Results: Without the group differences (p>0.05) pain decreasedin 4th and 6th week in all three treatment groups(p < 0.001). Increased strength of shoulder flexor, extensor androtator muscles were observed in both groups receiving activerESWT(p < 0.05). Strength of abductor’s muscles did not changein all three groups (p>0.05). There was no increase in the strengthof the evaluated muscles of the prESWT group (p>0.05).Conclusions: Different doses of rESWT were effective inimproving muscle strength in the diabetes-induced adhesivecapsulitis. In pain reduction, rESWT was effective without beingdifferent from placebo application.
WoS Q Kategorisi
Q1Kaynak
Diabetes Technology & TherapeuticsCilt
22Sayı
Supplement: 1Koleksiyonlar
- Bildiri Koleksiyonu [31]
- WoS İndeksli Yayınlar Koleksiyonu [6534]